Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,968 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contraceptive strategies for reducing the risk of reproductive cancers.
Aliabadi AR, Wilailak S, McNally O, Berek JS, Sridhar A; FIGO Committee on Contraception; FIGO Committee on Women's Cancer. Aliabadi AR, et al. Int J Gynaecol Obstet. 2024 May 9. doi: 10.1002/ijgo.15567. Online ahead of print. Int J Gynaecol Obstet. 2024. PMID: 38725288 Review.
MITO END-3: Efficacy of Avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy.
Pignata S, Califano D, Lorusso D, Arenare L, Bartoletti M, De Giorgi U, Andreetta C, Pisano C, Scambia G, Lombardi D, Farolfi A, Cinieri S, Passarelli A, Salutari V, De Angelis C, Mignogna C, Priolo D, Capoluongo ED, Tamberi S, Scaglione GL, Arcangeli V, De Cecio R, Scognamiglio G, Greco F, Spina A, Turinetto M, Russo D, Carbone V, Casartelli C, Schettino C, Perrone F. Pignata S, et al. Among authors: scambia g. Ann Oncol. 2024 May 2:S0923-7534(24)00128-5. doi: 10.1016/j.annonc.2024.04.007. Online ahead of print. Ann Oncol. 2024. PMID: 38704093
Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis.
Taliento C, Morciano G, Nero C, Froyman W, Vizzielli G, Pavone M, Salvioli S, Tormen M, Fiorica F, Scutiero G, Scambia G, Giorgi C, Greco P, Pinton P. Taliento C, et al. Among authors: scambia g. Int J Gynecol Cancer. 2024 Apr 23:ijgc-2024-005313. doi: 10.1136/ijgc-2024-005313. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38658022
Endometrial cancer with positive sentinel lymph nodes: pathologic characteristics of metastases as predictors of extent of lymphatic dissemination and prognosis.
Dinoi G, Ghoniem K, Huang Y, Zanfagnin V, Cucinella G, Langstraat C, Glaser G, Kumar A, Weaver A, McGree M, Fanfani F, Scambia G, Mariani A. Dinoi G, et al. Among authors: scambia g. Int J Gynecol Cancer. 2024 Apr 23:ijgc-2023-005181. doi: 10.1136/ijgc-2023-005181. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38658020
From 3D to 2D-4K laparoscopic sacral colpopexy: are we addicted to technology?
Morciano A, Marzo G, Schiavi MC, Zullo MA, Frigerio M, Tinelli A, Cervigni M, Scambia G. Morciano A, et al. Among authors: scambia g. Minim Invasive Ther Allied Technol. 2024 Apr 22:1-7. doi: 10.1080/13645706.2024.2343855. Online ahead of print. Minim Invasive Ther Allied Technol. 2024. PMID: 38648419
Obesity paradox: is a high body mass index positively influencing survival outcomes in gynecological cancers? A systematic review and meta-analysis.
Pavone M, Goglia M, Taliento C, Lecointre L, Bizzarri N, Fanfani F, Fagotti A, Scambia G, Marescaux J, Querleu D, Seeliger B, Akladios C. Pavone M, et al. Among authors: scambia g. Int J Gynecol Cancer. 2024 Apr 19:ijgc-2023-005252. doi: 10.1136/ijgc-2023-005252. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38642923
1,968 results